Haleon (HLN) Stock Price, News & Analysis

Company Overview

Haleon plc (NYSE: HLN) is a global consumer healthcare company headquartered in Weybridge, England. The company develops, manufactures and markets over-the-counter medicines, oral healthcare products, nutritional supplements and other consumer health products sold through pharmacies, retailers and e-commerce channels.

Its portfolio includes well-known brands such as Sensodyne, Polident and parodontax in oral healthcare; Advil, Panadol, Voltaren and Theraflu in pain relief and respiratory care; and Centrum and Emergen-C in vitamins, minerals and supplements. Haleon also markets products for digestive health, skin health and other everyday healthcare needs.

Haleon was created through the demerger of GSK’s consumer healthcare business and began operating as an independent public company in July 2022. It serves consumers in markets around the world, with products distributed across North America, Europe, Asia-Pacific, Latin America, Africa and other international regions. Its business is focused on helping consumers manage common health conditions and support daily wellness through accessible, nonprescription products.

Key Stats

• Today's Range: $9.23 to $9.32
• 50-Day Range: $8.73 to $10.19
• 52-Week Range: $8.65 to $11.28
• Volume: 11.30 million shs
• Average Volume: 21.54 million shs
• Market Capitalization: $40.93 billion
• P/E Ratio: 23.86
• Dividend Yield: 1.29%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Haleon Stock Analysis - MarketRank™

Haleon scored higher than 59% of companies evaluated by MarketBeat, and ranked 86th out of 168 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Haleon has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 2 strong buy ratings, 2 buy ratings, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Haleon has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.02%

Earnings Growth

Earnings for Haleon are expected to grow by 7.02% in the coming year, from $0.57 to $0.61 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Haleon is 23.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.06.

Price to Earnings Ratio vs. Sector

The P/E ratio of Haleon is 23.86, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 13.88.

Price to Earnings Growth Ratio

Haleon has a PEG Ratio of 2.09. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Haleon has a P/B Ratio of 1.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.56% of the float of Haleon has been sold short.

Short Interest Ratio / Days to Cover

Haleon has a short interest ratio ("days to cover") of 0.98, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Haleon has recently increased by 13.92%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Haleon pays a meaningful dividend of 1.32%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Haleon does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Haleon is 30.77%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Haleon will have a dividend payout ratio of 19.67% next year. This indicates that Haleon will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.42

News Sentiment

Haleon has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Haleon this week, compared to 1 article on an average week.

Search Interest

2 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

2 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Haleon insiders have not sold or bought any company stock.

Percentage Held by Institutions

6.67% of the stock of Haleon is held by institutions.

Company Calendar

• Last Earnings: 2/27/2025
• Record date for 9/17 Dividend: 8/14/2026
• Ex-Dividend for 9/17 Dividend: 8/14/2026
• Dividend Payable: 9/17/2026
• Today: 10/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:HLN
• CIK: 1900304
• Web: www.haleon.com
• Phone: 44-19-3282-2000
• Fax: N/A
• Employees: 24,535
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 23.86
• Forward P/E Ratio: 16.32
• P/E Growth: 2.1
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.38
• Current Ratio: 0.69
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $14.54 billion
• Price / Sales: 2.81
• Cash Flow: $0.61 per share
• Price / Cash Flow: 15.32
• Book Value: $4.88 per share
• Price / Book: 1.91

Miscellaneous

• Outstanding Shares: 4,398,270,000
• Free Float: N/A
• Market Cap: $40.93 billion
• Optionable: Not Optionable
• Beta: 0.14